Siza

In In de Weerd, Siza is represented by the Siza Volunteer Deployment department. The Siza volunteer work coordinator has her workplace at the Siza head office (at the Kemperbergerweg in Arnhem) and her workplace in In de Weerd. Thanks to the cooperation with the Vrijwilligerscentrale Arnhem and the other organizations within In de Weerd, beautiful initiatives have already been developed and In de Weerd is extremely suitable to orientate you as a resident of Arnhem (and surroundings) or to get information about volunteering within Siza. and about Siza in general.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

iPharma Expo 2022

24th World Congress On Pharmaceutical Research and Drug Discovery

The 2nd Saudi International Pharma Expo

13th Global Drug Delivery And Formulation Summit

Transforming Drug Discovery through AI 2022

Drug Delivery and Nanomedicine

Related News

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

RESEARCH

REGENERON, FOLLOWING IN LILLY'S FOOTSTEPS, WINS FDA EMERGENCY NOD FOR COVID-19 ANTIBODY COCKTAIL

Regeneron | November 24, 2020

Covid-19 Regeneron antibody cocktail, one of the drugs of President Donald Trump was given after he was infected with the SARS-COV-02 virus, had been cleaned for emergency use by the FDA. And, despite the towering vaccine slide, one analyst still sees therapy as a $ 1 billion-plus business. Authorization of Emergency Use (EUA) for Regn-COV2, a combination of monoclonal antibodies Kasarivimab and IMdevimab, marked the second for antibody therapy. The first to go to Bamlanivimab Eli...

PHARMACY MARKET

NOVARTIS' SANDOZ SPOTLIGHTS IMPORTANCE OF GENERIC DRUGS IN NEW SOCIAL CAMPAIGN

Novartis | December 17, 2020

Did you realize that 90% of remedies are composed for nonexclusive medications? Novartis' Sandoz is getting the news out about nonexclusive medication with such realities in its as of late dispatched "Request Generics" crusade. It's Sandoz's first significant instruction and mindfulness crusade via online media to advance the estimation of generics. The intended interest group is key partners—patients, clinicians, policymakers and payers—with mess...

PHARMACY MARKET

ANTARES PHARMA ANNOUNCES FDA ACCEPTANCE OF NDA RESUBMISSION FOR TLANDO®

Antares Pharma, Inc. | February 04, 2022

Antares Pharma, Inc. a specialty pharmaceutical company, announced that the U.S. Food and Drug Administration has accepted its New Drug Application resubmission for TLANDO®, an oral treatment for testosterone replacement therapy. The FDA designated the NDA as a Class 1 resubmission with a two-month review goal period and set a target action date of March 28, 2022, under the Prescription Drug User Fee Act. TLANDO® was granted tentative approval from the FDA as a twice-daily...

PHARMA TECH